Groowe Groowe / Newsroom / OCS
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

OCS News

Oculis Holding AG Ordinary shares

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AG - OCS

accessnewswire.com
OCS

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AG - OCS

globenewswire.com
OCS

Bronstein, Gewirtz & Grossman, LLC Encourages Oculis Holding AG (OCS) Stockholders to Inquire about Securities Investigation

accessnewswire.com
OCS

Oculis Announces First Patient Randomized in PREDICT-1 Registrational Trial of Licaminlimab, Advancing Precision Medicine in Dry Eye Disease

globenewswire.com
OCS

Oculis Announces First Patient Randomized in PREDICT-1 Registrational Trial of Licaminlimab, Advancing Precision Medicine in Dry Eye Disease

globenewswire.com
OCS

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oculis Holding AG - OCS

accessnewswire.com
OCS

Oculis to Present at the 47th Annual Goldman Sachs Global Healthcare Conference

globenewswire.com
OCS

Oculis to Present at the 47th Annual Goldman Sachs Global Healthcare Conference

globenewswire.com
OCS

OCS Investors Have Opportunity to Join Oculis Holding AG Fraud Investigation with the Schall Law Firm

prnewswire.com
OCS

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Oculis Holding AG (OCS) and Encourages Investors to Learn More About the Investigation

accessnewswire.com
OCS